The levels of the active NK cells (CD56+CD161+), the activated NK cells (CD56+CD314+), and the inactive NK cells (CD56+CD158+) from the peripheral blood of the patients with liver cancer, liver cirrhosis, and chronic hepatitis were regarded as the major detection indices and comparatively analyzed in detail. This evidence concerns the gene NCAM1 and cirrhosis of liver.